| Description |
| Product Type |
Product Size |
| Sachet
|
10'S |
| Product Company |
| Getz Pharma |
Omeprazole +Sodium Bicarbonate 40mg
|
| Product Type |
Product Size |
| Syrup |
1'S |
| Product Company |
| Highnoon Lab |
Sucralfate 120ml
|
| Product Type |
Product Size |
| Capsules |
21'S |
| Product Company |
| Getz Pharma |
Omeprazole 40mg
|
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Pfizer
|
Carboplatin 150mg/15ml
|
| Product Type |
Product Size |
| Tablet |
20'S |
| Product Company |
| Mass Pharma |
Amlodipine 5mg
|
| Product Type |
Product Size |
Product Company |
| Injection |
1'S |
Himmel Pharma |
|
| Content | Risek Insta is a combination of omeprazole, a proton-pump inhibitor and sodium bicarbonate, an antacid.Treatment of symptomatic gastroesophageal disease (GERD) without esophagitis; healing of erosive esophagitis; maintenance of healed erosive esophagitis; gastric and duodenal ulcer.
| " Sucralfate is a gastro-duodenal protective agent used in the treatment of gastric and duodenal ulcers and to prevent duodenal ulcer recurrence. "
| Omeprazole is used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). It works by decreasing the amount of acid your stomach
| Carboplatin is a platinum-containing chemotherapy medicine, which belongs to the alkylating agents group of medicines. It is used to treat various cancers. It prevents growth of cancerous cells by damaging their DNA that aids in its proliferation.
| Amlodipine is in a class of medications called calcium channel blockers. It lowers blood pressure by relaxing the blood vessels so the heart does not have to pump as hard. It controls chest pain by increasing the supply of blood to the heart
| Gemcitabine is a cytidine analog with two fluorine atoms.As a prodrug, gemcitabine is transformed into its active metabolites that work by replacing the building blocks of nucleic acids during DNA elongation, arresting tumour growth and promoting apoptosis of malignant cells. |
Reviews
There are no reviews yet.